Hep C Virus - FDA Approves New Chronic Hepatitis C Treatment

FDA Approves New Chronic Hepatitis C Treatment
FDA Approves New Chronic Hepatitis C Treatment FDA has approved a drug/biologic combination to treat chronic hepatitis C in patients with compensated liver disease who have relapsed following

Diabetes in hepatitis C
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29(2):328-333. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J et al. Further evidence for an

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073] Find a Clinical Trial Full Title : SHO-SAIKO-TO FOR PATIENTS WITH CHRONIC HEPATITIS